Company Overview and News
The financial sector rose on Thursday, bucking the negative tone of the overall market and gaining as the top-performing sector of the day. The group rose 0.8%. Among the biggest gainers were American Express Co. , which surged 5.9% a day after reporting results that topped analyst forecasts. Bank of New York Mellon Corp. rose 3.6% after its own results. The gains for the broader financial sector come as the 10-year Treasury note yield rose above 2.
Chuck Akre is an illustrious investor with a 29-year track record and is the founder, chairman and chief investment officer of Akre Capital Management. I take a closer look at Akre’s investment strategy and the firm’s most undervalued stock holdings below.
TransUnion (TRU - Free Report) is slated to release first-quarter 2018 results on Apr 20, before the opening bell.
Visa Inc. and Mastercard Inc., MA 0.63% the two largest U.S. card networks, said Wednesday that they’re planning to drop their longstanding initiatives to get online shoppers to use dedicated payment buttons.
Waste Management, Inc. (WM - Free Report) is slated to report first-quarter 2018 results on Apr 20, before the opening bell.
ManpowerGroup Inc. (MAN - Free Report) is scheduled to report first-quarter 2018 results on Apr 20, before the opening bell.
Q1 2018 was a volatile ride for Project $1M, however in spite of that, the portfolio still performed creditably.
Omnicom Group Inc. (OMC - Free Report) reported strong first-quarter 2018 results with revenues and earnings surpassing the Zacks Consensus Estimate.
Robert Half International Inc. (RHI - Free Report) is expected to report first-quarter 2018 results on Apr 19. Notably, the top- and bottom-line results of this leading staffing solutions provider surpassed the Zacks Consensus Estimate in two of the preceding four quarters.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
One of the best-performing large-cap stocks of the last decade, Visa Inc (NYSE:V) has struggled a bit of late. The Visa stock price still is up almost 6% YTD, but over the last two months trading in Visa has been choppy.
When playing professional poker, sometimes you need to lay down QQ pre-flop. Knowing not only your hand, but where it stands based on the environment is required.
Omnicom Group Inc. (OMC - Free Report) is scheduled to report first-quarter 2018 results on Apr 17, before the opening bell.
It's been six months since I presented three hedged portfolios and 10 top names in week 20 of my Marketplace service (October 12th). Here's how everything did.
Since the correction started in early February we have had dozens of headlines that caused volatility in the equity markets to spike. We’ve had panics over spiking interest rates, the threat of tariff wars, social media data breaches and more recently the potential of airstrikes in the Middle East.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET